219 related articles for article (PubMed ID: 21940940)
21. FcgammaRIIB-mediated inhibition of T-cell receptor signal transduction involves the phosphorylation of SH2-containing inositol 5-phosphatase (SHIP), dephosphorylation of the linker of activated T-cells (LAT) and inhibition of calcium mobilization.
Jensen WA; Marschner S; Ott VL; Cambier JC
Biochem Soc Trans; 2001 Nov; 29(Pt 6):840-6. PubMed ID: 11709085
[TBL] [Abstract][Full Text] [Related]
22. Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen.
Haynes MP; Li L; Sinha D; Russell KS; Hisamoto K; Baron R; Collinge M; Sessa WC; Bender JR
J Biol Chem; 2003 Jan; 278(4):2118-23. PubMed ID: 12431978
[TBL] [Abstract][Full Text] [Related]
23. The human high-affinity immunoglobulin G receptor activates SH2-containing inositol phosphatase (SHIP).
Cameron AJ; Allen JM
Immunology; 1999 Aug; 97(4):641-7. PubMed ID: 10457218
[TBL] [Abstract][Full Text] [Related]
24. Regulated expression and inhibitory function of Fcgamma RIIb in human monocytic cells.
Tridandapani S; Siefker K; Teillaud JL; Carter JE; Wewers MD; Anderson CL
J Biol Chem; 2002 Feb; 277(7):5082-9. PubMed ID: 11741917
[TBL] [Abstract][Full Text] [Related]
25. Src kinase mediates angiotensin II-dependent increase in pulmonary endothelial nitric oxide synthase.
Li X; Lerea KM; Li J; Olson SC
Am J Respir Cell Mol Biol; 2004 Sep; 31(3):365-72. PubMed ID: 15191917
[TBL] [Abstract][Full Text] [Related]
26. The monocyte Fcgamma receptors FcgammaRI/gamma and FcgammaRIIA differ in their interaction with Syk and with Src-related tyrosine kinases.
Huang ZY; Hunter S; Kim MK; Chien P; Worth RG; Indik ZK; Schreiber AD
J Leukoc Biol; 2004 Aug; 76(2):491-9. PubMed ID: 15136586
[TBL] [Abstract][Full Text] [Related]
27. The effect of insulin to decrease neointimal growth after arterial injury is endothelial nitric oxide synthase-dependent.
Guo J; Breen DM; Pereira TJ; Dalvi PS; Zhang H; Mori Y; Ghanim H; Tumiati L; Fantus IG; Bendeck MP; Dandona P; Rao V; Dolinsky VW; Heximer SP; Giacca A
Atherosclerosis; 2015 Jul; 241(1):111-20. PubMed ID: 25974101
[TBL] [Abstract][Full Text] [Related]
28. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
Nakamura K; Brauweiler A; Cambier JC
J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
[TBL] [Abstract][Full Text] [Related]
29. Protein interactions of Src homology 2 (SH2) domain-containing inositol phosphatase (SHIP): association with Shc displaces SHIP from FcgammaRIIb in B cells.
Tridandapani S; Pradhan M; LaDine JR; Garber S; Anderson CL; Coggeshall KM
J Immunol; 1999 Feb; 162(3):1408-14. PubMed ID: 9973396
[TBL] [Abstract][Full Text] [Related]
30. Fcγ receptor IIb strongly regulates Fcγ receptor-facilitated T cell activation by dendritic cells.
van Montfoort N; 't Hoen PA; Mangsbo SM; Camps MG; Boross P; Melief CJ; Ossendorp F; Verbeek JS
J Immunol; 2012 Jul; 189(1):92-101. PubMed ID: 22649202
[TBL] [Abstract][Full Text] [Related]
31. Intravenous immunoglobulins modulate neutrophil activation and vascular injury through FcγRIII and SHP-1.
Jang JE; Hidalgo A; Frenette PS
Circ Res; 2012 Apr; 110(8):1057-66. PubMed ID: 22415018
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies.
Chu SY; Vostiar I; Karki S; Moore GL; Lazar GA; Pong E; Joyce PF; Szymkowski DE; Desjarlais JR
Mol Immunol; 2008 Sep; 45(15):3926-33. PubMed ID: 18691763
[TBL] [Abstract][Full Text] [Related]
33. Negative regulation of mast cell proliferation by FcgammaRIIB.
Malbec O; Attal JP; Fridman WH; Daëron M
Mol Immunol; 2002 Sep; 38(16-18):1295-9. PubMed ID: 12217398
[TBL] [Abstract][Full Text] [Related]
34. Antigen-induced oligomerization of the B cell receptor is an early target of Fc gamma RIIB inhibition.
Liu W; Won Sohn H; Tolar P; Meckel T; Pierce SK
J Immunol; 2010 Feb; 184(4):1977-89. PubMed ID: 20083655
[TBL] [Abstract][Full Text] [Related]
35. Protein-tyrosine phosphatase SHP-1 is dispensable for FcgammaRIIB-mediated inhibition of B cell antigen receptor activation.
Nadler MJ; Chen B; Anderson JS; Wortis HH; Neel BG
J Biol Chem; 1997 Aug; 272(32):20038-43. PubMed ID: 9242674
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1.
Ching LC; Kou YR; Shyue SK; Su KH; Wei J; Cheng LC; Yu YB; Pan CC; Lee TS
Cardiovasc Res; 2011 Aug; 91(3):492-501. PubMed ID: 21493704
[TBL] [Abstract][Full Text] [Related]
37. ICAM-1-activated Src and eNOS signaling increase endothelial cell surface PECAM-1 adhesivity and neutrophil transmigration.
Liu G; Place AT; Chen Z; Brovkovych VM; Vogel SM; Muller WA; Skidgel RA; Malik AB; Minshall RD
Blood; 2012 Aug; 120(9):1942-52. PubMed ID: 22806890
[TBL] [Abstract][Full Text] [Related]
38. C-Reactive Protein Impairs Dendritic Cell Development, Maturation, and Function: Implications for Peripheral Tolerance.
Jimenez RV; Wright TT; Jones NR; Wu J; Gibson AW; Szalai AJ
Front Immunol; 2018; 9():372. PubMed ID: 29556231
[TBL] [Abstract][Full Text] [Related]
39. Effect of C-reactive protein on Fcgamma receptor II in cultured bovine endothelial cells.
Escribano-Burgos M; López-Farré A; del Mar González M; Macaya C; García-Méndez A; Mateos-Cáceres PJ; Alonso-Orgaz S; Carrasco C; Rico LA; Porres Cubero JC
Clin Sci (Lond); 2005 Jan; 108(1):85-91. PubMed ID: 15387799
[TBL] [Abstract][Full Text] [Related]
40. N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase.
Hou HH; Hammock BD; Su KH; Morisseau C; Kou YR; Imaoka S; Oguro A; Shyue SK; Zhao JF; Lee TS
Cardiovasc Res; 2012 Jan; 93(1):120-9. PubMed ID: 22072631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
